Sign in

CIK 0000948320 · Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
760238453
Phone
(866) 351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-31 Galluppi Stefan Chief Innovation Officer Grant or award +30,000 165,449
2025-03-31 Benathen Marc David Chief Financial Officer Grant or award +75,000 464,554
2025-03-31 Yecies Eric Harold Chief Legal Officer & GC Grant or award +18,750 340,000
2025-03-31 Yecies Eric Harold Chief Legal Officer & GC Grant or award +30,000 370,000
2025-03-19 Schreiber Justin Chairman and CEO Gift −27,994 2,625,721
2025-03-19 Schreiber Justin Chairman and CEO Gift +13,997 13,997
2025-03-19 Schreiber Justin Chairman and CEO Gift +13,997 13,997
2025-03-14 FRIEDEMAN JESSICA Chief Marketing Officer Sale −30,000 $5.66 $170K 170,000
2025-03-07 STAN MARIA E. Chief Accounting Officer Grant or award +20,000 68,125
2025-03-07 Galluppi Stefan Chief Innovation Officer Grant or award +30,000 135,449
2025-03-07 Benathen Marc David Chief Financial Officer Grant or award +87,000 389,554
2025-03-07 FRIEDEMAN JESSICA Chief Marketing Officer Grant or award +50,000 200,000
2025-03-07 Yecies Eric Harold Chief Legal Officer & GC Grant or award +50,000 321,250
2025-03-07 Wijnker Dennis Chief Technology Officer Grant or award +25,000 125,000
2025-03-06 STAN MARIA E. Chief Accounting Officer Grant or award +20,000 48,125
2025-03-06 Galluppi Stefan Chief Innovation Officer Grant or award +60,000 105,449
2025-02-14 Schreiber Justin Chief Executive Officer Sale 10b5-1 −50,000 $7.55 $378K 2,653,715
2025-01-02 Schreiber Justin Chief Executive Officer Sale 10b5-1 −25,000 $5.19 $130K 2,703,715
2024-12-20 LAROVERE JOAN Director Grant or award +9,685 84,685
2024-12-06 DiTrolio Joseph Director Grant or award +24,648 243,048

Page 3 of 8 · 146 trades